Effect of YM-126414 on glucose uptake and redistribution of glucose transporter isotype 4 in muscle cells

被引:7
作者
Shimokawa, T
Kagami, M
Kato, M
Kurosaki, E
Shibasaki, M
Katoh, M
机构
[1] Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan
[2] Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
关键词
C2C12; cell; glucose transporter isotype 4; insulin resistance; YM-126414;
D O I
10.1016/S0014-2999(00)00880-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We discovered a novel compound, YM-126414 [1,3,3-trimethyl-2-(2-phenylaminovinyl)-3H-indolium perchlorate], which stimulates glucose uptake in skeletal muscle cells in vitro. This compound increased the rate of consumption of glucose by C2C12 mouse myoblast cells in a dose-dependent manner (EC50 = 10 nM). To investigate the mechanism of this stimulation, we determined the redistribution of insulin-regulatable glucose transporter isotype 4 (Glut4). When fully differentiated C2C12 cells stably expressing myc-tagged Glut4 protein were treated with YM-126414, redistribution was dramatically increased in a dose-dependent manner (EC50 = 21 nM). These results indicate that YM-126414 is a novel glucose uptake stimulator for muscle cells by causing up-regulation of Glut4 redistribution in differentiated muscle cells. Our findings for the in vitro effects of YM-126414 suggest a direction for the development of new drugs for the treatment of type 2 diabetes. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 26 条
[1]   Substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as hypoglycemic agents [J].
Aicher, TD ;
Balkan, B ;
Bell, PA ;
Brand, LJ ;
Cheon, SH ;
Deems, RO ;
Fell, JB ;
Fillers, WS ;
Fraser, JD ;
Gao, JP ;
Knorr, DC ;
Kahle, GG ;
Leone, CL ;
Nadelson, J ;
Simpson, R ;
Smith, HC .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (23) :4556-4566
[2]   Exercise and insulin sensitivity: A review [J].
Borghouts, LB ;
Keizer, HA .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2000, 21 (01) :1-12
[3]   Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle [J].
Cusi, K ;
Maezono, K ;
Osman, A ;
Pendergrass, M ;
Patti, ME ;
Pratipanawatr, T ;
DeFronzo, RA ;
Kahn, CR ;
Mandarino, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) :311-320
[4]  
DeFronzo RA, 1997, DIABETES REV, V5, P177
[5]   Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance [J].
Garvey, WT ;
Maianu, L ;
Zhu, JH ;
Brechtel-Hook, G ;
Wallace, P ;
Baron, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2377-2386
[6]   Identification of wortmannin-sensitive targets in 3T3-L1 adipocytes - Dissociation of insulin-stimulated glucose uptake and GLUT4 translocation [J].
Hausdorff, SF ;
Fingar, DC ;
Morioka, K ;
Garza, LA ;
Whiteman, EL ;
Summers, SA ;
Birnbaum, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (35) :24677-24684
[7]   Evidence for 5′AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport [J].
Hayashi, T ;
Hirshman, MF ;
Kurth, EJ ;
Winder, WW ;
Goodyear, LJ .
DIABETES, 1998, 47 (08) :1369-1373
[8]   Glucose transporters and insulin action: Some insights into diabetes management [J].
Jung, CY ;
Lee, W .
ARCHIVES OF PHARMACAL RESEARCH, 1999, 22 (04) :329-334
[9]  
KANAI F, 1993, J BIOL CHEM, V268, P14523
[10]   Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes [J].
Kennedy, JW ;
Hirshman, MF ;
Gervino, EV ;
Ocel, JV ;
Forse, RA ;
Hoenig, SJ ;
Aronson, D ;
Goodyear, LJ ;
Horton, ES .
DIABETES, 1999, 48 (05) :1192-1197